HB 1265 - AS INTRODUCED
HOUSE BILL 1265
SPONSORS: Rep. Adjutant, Graf. 17; Rep. Kenney, Straf. 6; Rep. St. Clair, Belk. 9
COMMITTEE: Health, Human Services and Elderly Affairs
This bill changes the definition of "qualifying medical condition" in the statute governing the use of cannabis for therapeutic purposes.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty
Be it Enacted by the Senate and House of Representatives in General Court convened:
IX.(a) "Qualifying medical condition" means a medical condition diagnosed by a provider for which cannabis is prescribed for such condition which may include the presence of:
(1) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, Ehlers-Danlos syndrome, or one or more injuries or conditions that has resulted in one or more qualifying symptoms under subparagraph (2); and
(2) A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer's disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms; or
(b) "Qualifying medical condition" may mean:
(1) Moderate to severe chronic pain.
(2) Severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects.
(3) Moderate or severe post-traumatic stress disorder.
|Jan. 29, 2020||House||Hearing|
|Feb. 13, 2020||House||Exec Session|
|Feb. 18, 2020||House||Exec Session|
|Sept. 3, 2020||House||Exec Session|
: Interim Study Report: Not Recommended for Future Legislation (Vote 18-0)
Sept. 3, 2020: Full Committee Work Session: 09/03/2020 02:00 pm Members of the public may attend using this link: https://www.zoom.us/j/93480617681 - Executive Session to Follow
March 11, 2020: Refer for Interim Study: MA VV 03/11/2020 HJ 7 P. 31
: Committee Report: Refer for Interim Study (Vote 17-0; CC)
March 11, 2020: Committee Report: Refer for Interim Study for 03/11/2020 (Vote 17-0; CC) HC 10 P. 18
Feb. 18, 2020: ==CONTINUED== Executive Session: 02/18/2020 01:00 pm LOB 205 (if not exec'd on the 13th)
Feb. 13, 2020: Executive Session: 02/13/2020 11:00 am LOB 205
Feb. 12, 2020: Subcommittee Work Session: 02/12/2020 10:00 am LOB 104
Jan. 29, 2020: Public Hearing: 01/29/2020 01:00 pm LOB 205
Jan. 8, 2020: Introduced 01/08/2020 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 15